 |
Friday October 23rd, 50 stock ideas |
| Most viewed |
|
 | Putting bear cases to rest Medpace authorized $1 billion of buybacks through 2028 after Q3 revenue rose 8.5% to $716 million; service revenue grew roughly 12% as pass-through costs normalized. |
|
| Technology and AI |
|
|
|
|
|
 | Capital Wars CoreWeave’s $35 billion to $39 billion 2026 spending plan relies on debt as unsecured yields reach 15%, making its GPU cloud expansion a barometer for AI financing. |
|
|
| Consumer Discretionary |
|
|
|
|
|
| |
| Financials |
 | TSOH Weekly Roundup (10/23/2026) TSOH Weekly Roundup covers Ally’s improving credit and capital returns, Pepsi’s weak beverage brands, and Match Group’s plan to revive Tinder. |
|
|
|
|
|
|
| Energy |
|
| Healthcare |
|
|
|
|
| Communication Services |
|
|
|
|
|
|
| Consumer Staples |
|
|
|
| Industrials |
|
|
|
|
|
|
| Materials |
|
|
|
| Real Estate |
|
|
| Investor letters |
| Scorecard #55 – The Mountain |
| Q3 2026 |
| Deep Value Strategy Taking Advantage of Low Market Expectations |
| Cracks in the piñata |
| Exponential – 3rd quarter, 2026 |
| Guinness Global Equity Income Investment Commentary – October 2026 |
| The Price of Compounding |
| Value Fund Q226 |
| Real Estate Value Fund |
| Third Avenue Real Estate Value Fund Portfolio Manager Commentary |
|